The fact
This spike occurred at the end of the session, well above the usual average.
Investors are monitoring the French biotech's clinical developments.
Click the link to read an article on the topic:
This spike occurred at the end of the session, well above the usual average.
Investors are monitoring the French biotech's clinical developments.